BNT327, BNT314, BNT327 1-15
BNT314-02
Phase 2 small_molecule active
Quick answer
BNT327, BNT314, BNT327 1-15 for Metastatic colorectal cancer is a Phase 2 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Metastatic colorectal cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active